nitrofurantoin has been researched along with Cirrhosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnhart, H; Bonkovsky, H; Chalasani, N; Dellinger, A; Fontana, RJ; Gu, J; Hoofnagle, JH; Kleiner, DE; Lammert, C; Li, YJ; Navarro, V; Nicoletti, P; Phillips, E; Schwantes-An, TH | 1 |
1 other study(ies) available for nitrofurantoin and Cirrhosis
| Article | Year |
|---|---|
Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.
Topics: Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Dyphylline; Fibrosis; Hepatitis, Autoimmune; HLA Antigens; HLA-DRB1 Chains; Humans; Necrosis; Nitrofurantoin; Risk Factors | 2023 |